Welcome Arterys: integrating medical imaging insights to drive better outcomes for patients

Authors Ryan Fukushima, Chief Operating Officer

Radiology and the use of imaging technology to diagnose and treat disease is a key aspect of modern clinical care. X-ray, CT, MRI, ultrasound, and PET scans – the most common modalities of imaging-based diagnostics – help doctors look for disease in different parts of the body, identify its presence, and track its progress or its retreat. These images provide physicians and the care team with critical information to make the best decisions on behalf of their patients.

Here at Tempus, we’ve always known that incorporating radiology and imaging data modalities would be critical to achieve our mission to leverage data and artificial intelligence (AI) to deliver a personalized healthcare experience for every patient. But we also knew we couldn’t do it alone as these images are stored in completely different systems and are rarely connected to a patient’s electronic medical record.

Enter Arterys, who built an AI platform specifically designed for medical imaging, enabling physicians to make informed treatment decisions and deliver better patient care. Alongside their cloud-based platform, Arterys offers a comprehensive set of industry-leading, FDA cleared and CE marked clinical AI workflow solutions and medical devices– adding value across a wide range of sub-specialties with a single and seamless integration to the provider hospital systems. Most importantly, Arterys shares a common mission with Tempus to create a world where clinical care is data-driven and intelligent, and available for every patient.

I’m proud that Arterys is now a Tempus company, and together, we aim to bring this mission to life by adding Arterys’ capabilities to Tempus’ existing offerings for physicians and researchers, enhancing one of the world’s largest libraries of multimodal data and an operating system to make that data accessible and useful. Specifically, we plan to fully integrate our two platforms and deploy our collective suite of radiology and pathology-based AI applications, which currently includes eight FDA cleared solutions, supporting physicians in providing data-driven insights to improve patient care.

For Physicians

We can now provide physicians with a more comprehensive patient view in our portal, inclusive of not just molecular and clinical data and pathology images, but also radiology images. With all of these critical data modalities in one place, we can support physicians encapsulating the full patient journey from patient diagnosis, treatment decision-making, and treatment monitoring and response over time.

For Researchers

Joining forces with Arterys strengthens our position in radiology, a key element of our platform, and better supports our existing customers by adding new data modalities and capabilities that support the research and the development of cutting-edge therapeutics. Medical imaging represents a less-invasive approach to understanding patient outcomes and provides a longitudinal view of a patient’s journey from diagnosis throughout the course of their treatment.

Until now, data modalities were often kept in silos, hindering the progress of many precision medicine opportunities. Tempus has built the data architecture to bring these multimodal datasets together to change the paradigm in clinical research with a deployment solution to launch AI applications into clinical care.

As we enter 2023, I am more confident than ever that we are building a better future of data-driven precision medicine. With AI insights and vast multimodal data at our fingertips, Tempus is one step closer to realizing our vision of delivering AI-enabled diagnostic solutions to provide the best clinical care while we revolutionize research efforts. I look forward to continuously delivering new ways of integrating multimodal datasets to make diagnostics more intelligent, improving outcomes for patients and supporting development of novel therapeutics to help individuals live longer and healthier lives.

Related Content

View more